window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 17, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Movers and Shakers

  • Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    Nucleome Therapeutics appoints Michelle Morrow as chief scientific officer

    Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    IgniteData appoints Laura Hilty as CSO and Joe Lengfellner as CPO amid Series A funding close

    IgniteData has appointed Laura Hilty as chief strategy officer and [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas

    Hans Schambye appointed as CEO of BOOST Pharma as BT‑101 advances toward Phase 3

    BOOST Pharma has appointed Hans Schambye as its new chief [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Levicept appoints James Sandy as chief development officer to advance LEVI-04 for osteoarthritis

    Levicept has strengthened its executive team with the appointment of [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Manufacturing & Supply Chain

    Spore.Bio appoints Michael Miller as VP of scientific and regulatory affairs

    Spore.Bio has appointed Michael Miller as vp of scientific and [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Delivery & Formulation,Medical devices

    ViCentra appoints Reman McDonagh as vice president, global marketing to support Kaleido scale-up

    ViCentra has appointed Reman McDonagh as vice president, global marketing [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Therapeutic Areas

    TECregen appoints Dr Klaas Zuideveld as CEO to advance thymus regeneration platform

    TECregen has appointed Dr Klaas Zuideveld as chief executive officer [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    iOrganBio appoints Karol Jarzabek as chief operating officer

    iOrganBio has appointed Karol Jarzabek as chief operating officer to [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    VoxCell appoints chief commercial officer as demand grows for predictive non-clinical models

    VoxCell, a Canadian biotechnology company developing vascularized 3D tissue models, [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Opinion & Events,Therapeutic Areas

    START appoints Dr Navid Hafez as director of clinical research at new Los Angeles site

    The START Center for Cancer Research has appointed Dr Navid [...]

    May 5, 2026
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Vertex reports positive CASGEVY data in children and completes UK submission
    Categories: Advanced Therapies, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Poolbeg presents preclinical POLB 001 data at EHA Congress
    Categories: Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Scenic Biotech joins Michael J. Fox Foundation Parkinson’s research programme
    Categories: Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top